EXPEZOL

This brand name is authorized in Nigeria.

Active ingredients

The drug EXPEZOL contains one active pharmaceutical ingredient (API):

1
UNII F4216019LN - ALBENDAZOLE
 

Albendazole causes degenerative alterations in the tegument and intestinal cells of the worm by binding to the colchicine-sensitive site of tubulin, thus inhibiting its polymerization or assembly into microtubules.

 
Read more about Albendazole

Packages

This drug has been approved in Nigeria as follows:

Identifier Form Presentation Description Approval
A4-4983 Tablet EXPEZOL TABLET 200mg TAB 200 mg 12 EXPEZOL TABLET 200mg ALBENDAZOLE 200mg Albendazole 200mg Magnesium Stearate 3mg Maize Starch 98mg Purified Talk 6mg Colloidal Anhydrous Silica 3mg Sodium Starch Glycollate 10mg Croscarmellose Sodium 10mg Purified Water 0.0768ml A4-4983 Drugs Imported Products 12 Prescription Only Medicine (POM) 18/01/2022 SWISS PHARMA NIGERIA LIMITED, , DOPEMU ROAD, IKEJA LAGOS 17745276 swipha@swiphanigeria.com Vapi Care Pharma Pvt Ltd, plot No 225/3 GIDC Vapi 396- 195, Gujarat India , India 26/04/2023
A4-4984 Suspension EXPEZOL SUSPENSION SUSP 200 mg/5 mL 1 x 10ml EXPEZOL SUSPENSION ALBENDAZOLE SUSPENSION Albendazole 200 mg/5ml Polysorbate-80 2.000 mg Glycerin 60.00 mg Sorbitol 70% 200.0 mg Propylene glycol 15.00 mg Sugar (Sucrose) 500.0 mg Methyl hydroxybenzoate 1.501 mg Propyl hydroxybenzoate 0.149 mg Carmellose Sodium 2.000mg Colloidal Anhydrous Silica 4.000 mg Flavour raspberry 1.000 mg Citric Acid Monohydrate 1.941 mg Purified Water Q.S. A4-4984 Drugs Imported Products 1 x 10ml Over The Counter (OTC) 20/03/2023 SWISS PHARMA NIGERIA LIMITED, , DOPEMU ROAD, IKEJA LAGOS 17745276 swipha@swiphanigeria.com VAPI CARE PHARMA PVT LTD- 396-195, VAPI CARE PHARMA PVT LTD., Plot No 225/3, G.I.D.C, Near Morarji Circle, Vapi -396-195, Gujarat, INDIA , India 31/08/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
P02CA03 Albendazole P Antiparasitic products, insecticides and repellents → P02 Anthelmintics → P02C Antinematodal agents → P02CA Benzimidazole derivatives
Discover more medicines within P02CA03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
NG Registered Drug Product Database A4-4983, A4-4984

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.